Skip to main content
Clinical Trials/EUCTR2018-000026-54-SE
EUCTR2018-000026-54-SE
Active, not recruiting
Phase 1

A comparison of sedatives used during gastroscopy, alfentanil vs midazolam

Medicinkliniken, Sjukhuset Lidköping0 sites150 target enrollmentJuly 23, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Sedative effect during gastroscopy
Sponsor
Medicinkliniken, Sjukhuset Lidköping
Enrollment
150
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 23, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medicinkliniken, Sjukhuset Lidköping

Eligibility Criteria

Inclusion Criteria

  • Patient between 18\-80 years old
  • Refererred for policlinical routine gastroscopy
  • In need of sedative agent
  • Patient can communicate
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 50

Exclusion Criteria

  • Allergies to any of the used agents
  • Unable to communicate
  • Any planned therapuetical interventions
  • Patient has a suspected alcohol, narcotic och abuse of other drugs, or previous abuse
  • Pregnant patient
  • Severe lung disease

Outcomes

Primary Outcomes

Not specified

Similar Trials